Accredited Learning Module (ALM)

This accredited learning module explores how to initiate injectable therapy in a patient with type 2 diabetes who remains above their glycaemic target despite taking dual or triple oral therapy. The activity works through 3 in-depth case-studies: a patient with uncomplicated T2D, a patient with ASCVD risk, and a patient with established ASCVD.

Haemochromatosis is the most common genetic disorder in Caucasian people of northern European descent, with signs and symptoms that are highly variable. Living with haemochromatosis is an individual journey that requires consistent, medically supported self-management strategies guided by a positive attitude and awareness of their condition to achieve optimal disease management. This activity aims to educate GPs about the genetic cause of hereditary haemochromatosis and management techniques such as therapeutic venesection.

Heart failure is a significant health issue in Australia, with complex diagnostic and management methods that must be tailored to each patient. This ALM comprehensively covers the many stages of heart failure management including the identification of risk factors, diagnosis and investigations, pharmacological and non-pharmacological management, management of progression and comorbidities, the use of implantable devices and end-of-life care, and multidisciplinary care programs.

This activity will guide GPs through the epidemiology of skin cancers in Australia, skin cancer prevention, balanced approach to UV and vitamin D awareness and the diagnosis and management of melanoma and the most common non-melanoma skin cancers.